Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 41 | 2024 | 2066 | 5.180 |
Why?
|
Coronary Artery Disease | 35 | 2024 | 6662 | 4.780 |
Why?
|
Acute Coronary Syndrome | 23 | 2024 | 2363 | 4.570 |
Why?
|
Drug-Eluting Stents | 9 | 2024 | 759 | 3.990 |
Why?
|
Heart Valve Prosthesis Implantation | 27 | 2024 | 1584 | 3.980 |
Why?
|
Aortic Valve | 35 | 2024 | 1998 | 2.560 |
Why?
|
Platelet Aggregation Inhibitors | 19 | 2024 | 3202 | 2.530 |
Why?
|
Atrial Fibrillation | 17 | 2024 | 5202 | 2.310 |
Why?
|
Treatment Outcome | 121 | 2024 | 64968 | 2.270 |
Why?
|
Fibrinolytic Agents | 10 | 2023 | 2168 | 2.240 |
Why?
|
Coronary Artery Bypass | 11 | 2023 | 2274 | 2.220 |
Why?
|
Ultrasonography, Interventional | 10 | 2024 | 1503 | 2.200 |
Why?
|
Thrombosis | 9 | 2023 | 3053 | 2.190 |
Why?
|
Hospital Mortality | 33 | 2024 | 5422 | 2.130 |
Why?
|
Ventricular Dysfunction, Left | 9 | 2023 | 2130 | 2.020 |
Why?
|
Acute Kidney Injury | 9 | 2024 | 1936 | 1.900 |
Why?
|
Endovascular Procedures | 10 | 2024 | 2145 | 1.900 |
Why?
|
Randomized Controlled Trials as Topic | 39 | 2024 | 10343 | 1.890 |
Why?
|
Heart Valve Prosthesis | 13 | 2023 | 1494 | 1.880 |
Why?
|
Heart Failure | 24 | 2024 | 11836 | 1.860 |
Why?
|
Myocardial Infarction | 16 | 2024 | 11894 | 1.780 |
Why?
|
Shock, Cardiogenic | 9 | 2024 | 736 | 1.690 |
Why?
|
Renal Dialysis | 7 | 2022 | 1802 | 1.630 |
Why?
|
Anticoagulants | 13 | 2023 | 4899 | 1.620 |
Why?
|
Heart-Assist Devices | 11 | 2024 | 1292 | 1.610 |
Why?
|
Mitral Valve Insufficiency | 10 | 2024 | 1420 | 1.610 |
Why?
|
Hemorrhage | 21 | 2024 | 3606 | 1.540 |
Why?
|
Extracorporeal Membrane Oxygenation | 4 | 2023 | 1456 | 1.530 |
Why?
|
Cardiac Valve Annuloplasty | 2 | 2022 | 51 | 1.510 |
Why?
|
Coronary Angiography | 21 | 2024 | 4561 | 1.490 |
Why?
|
Humans | 277 | 2024 | 760276 | 1.460 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 3 | 2021 | 537 | 1.390 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 347 | 1.390 |
Why?
|
Pulmonary Embolism | 5 | 2023 | 2544 | 1.360 |
Why?
|
Stroke | 20 | 2024 | 9946 | 1.340 |
Why?
|
Postoperative Complications | 24 | 2024 | 15684 | 1.260 |
Why?
|
New York City | 8 | 2022 | 723 | 1.240 |
Why?
|
Angioplasty, Balloon, Coronary | 5 | 2020 | 1880 | 1.220 |
Why?
|
Hypertension, Pulmonary | 3 | 2023 | 1570 | 1.210 |
Why?
|
Peripheral Arterial Disease | 8 | 2023 | 1316 | 1.210 |
Why?
|
Saphenous Vein | 2 | 2021 | 538 | 1.200 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2023 | 1004 | 1.190 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2022 | 355 | 1.150 |
Why?
|
Risk Factors | 78 | 2024 | 74278 | 1.150 |
Why?
|
Stroke Volume | 14 | 2023 | 5513 | 1.120 |
Why?
|
Intra-Aortic Balloon Pumping | 4 | 2024 | 227 | 1.100 |
Why?
|
Alanine | 4 | 2023 | 607 | 1.100 |
Why?
|
Registries | 14 | 2024 | 8450 | 1.080 |
Why?
|
Hemoglobins | 3 | 2021 | 1521 | 1.070 |
Why?
|
Thrombolytic Therapy | 5 | 2023 | 2109 | 1.060 |
Why?
|
Purinergic P2Y Receptor Antagonists | 5 | 2023 | 380 | 1.050 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2024 | 2296 | 1.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2024 | 329 | 1.020 |
Why?
|
Coronary Vessel Anomalies | 3 | 2024 | 316 | 0.960 |
Why?
|
Bioprosthesis | 4 | 2023 | 599 | 0.960 |
Why?
|
Adenosine Monophosphate | 3 | 2021 | 283 | 0.940 |
Why?
|
Retrospective Studies | 64 | 2024 | 80311 | 0.940 |
Why?
|
Coronavirus Infections | 6 | 2021 | 3086 | 0.940 |
Why?
|
Steroids | 4 | 2021 | 928 | 0.930 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2024 | 87 | 0.920 |
Why?
|
Coronary Vessels | 7 | 2024 | 3112 | 0.910 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2021 | 1521 | 0.910 |
Why?
|
Patient Readmission | 13 | 2023 | 3329 | 0.900 |
Why?
|
Japan | 12 | 2023 | 1369 | 0.860 |
Why?
|
Heart Diseases | 4 | 2020 | 2810 | 0.830 |
Why?
|
Adrenal Cortex Hormones | 2 | 2021 | 1870 | 0.820 |
Why?
|
Blood Transfusion | 3 | 2024 | 1328 | 0.790 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2024 | 146 | 0.780 |
Why?
|
Nose Diseases | 1 | 2022 | 79 | 0.770 |
Why?
|
Aortic Aneurysm, Abdominal | 6 | 2024 | 1199 | 0.770 |
Why?
|
Heart Transplantation | 10 | 2023 | 3217 | 0.760 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2024 | 693 | 0.750 |
Why?
|
Blood Vessel Prosthesis Implantation | 4 | 2024 | 1426 | 0.750 |
Why?
|
Mucormycosis | 1 | 2022 | 103 | 0.740 |
Why?
|
Aged | 66 | 2024 | 169002 | 0.730 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 233 | 0.730 |
Why?
|
Venous Thromboembolism | 3 | 2023 | 1866 | 0.730 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 899 | 0.730 |
Why?
|
Coronary Restenosis | 1 | 2023 | 426 | 0.720 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3206 | 0.710 |
Why?
|
Aortic Rupture | 2 | 2020 | 313 | 0.710 |
Why?
|
Risk Assessment | 30 | 2024 | 24086 | 0.700 |
Why?
|
Antimetabolites | 1 | 2020 | 127 | 0.700 |
Why?
|
Ablation Techniques | 1 | 2023 | 249 | 0.690 |
Why?
|
Orbital Diseases | 1 | 2022 | 178 | 0.690 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 1025 | 0.690 |
Why?
|
Catheter Ablation | 3 | 2022 | 2755 | 0.680 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5884 | 0.670 |
Why?
|
Troponin | 2 | 2020 | 516 | 0.670 |
Why?
|
Male | 88 | 2024 | 359427 | 0.670 |
Why?
|
Troponin I | 2 | 2020 | 634 | 0.670 |
Why?
|
Pharmacy | 1 | 2021 | 92 | 0.650 |
Why?
|
Glucosides | 1 | 2024 | 536 | 0.650 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2877 | 0.640 |
Why?
|
Vitamin K | 4 | 2023 | 322 | 0.640 |
Why?
|
Hospitalization | 12 | 2024 | 10761 | 0.620 |
Why?
|
Female | 85 | 2024 | 391024 | 0.620 |
Why?
|
Vascular Diseases | 2 | 2024 | 1180 | 0.610 |
Why?
|
Coated Materials, Biocompatible | 1 | 2020 | 319 | 0.610 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2017 | 10 | 0.600 |
Why?
|
Aged, 80 and over | 34 | 2024 | 58953 | 0.600 |
Why?
|
Embolism | 1 | 2021 | 408 | 0.600 |
Why?
|
Stents | 7 | 2024 | 3306 | 0.600 |
Why?
|
Heart Arrest | 3 | 2023 | 1506 | 0.600 |
Why?
|
Endarterectomy, Carotid | 1 | 2023 | 560 | 0.590 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6499 | 0.570 |
Why?
|
Middle Aged | 52 | 2024 | 220179 | 0.570 |
Why?
|
Mitral Valve | 9 | 2024 | 1487 | 0.570 |
Why?
|
Time Factors | 25 | 2024 | 40141 | 0.560 |
Why?
|
Myocardial Revascularization | 5 | 2023 | 841 | 0.560 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 435 | 0.560 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 942 | 0.560 |
Why?
|
Lower Extremity | 3 | 2023 | 1196 | 0.560 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 881 | 0.550 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2022 | 1705 | 0.540 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2023 | 3333 | 0.540 |
Why?
|
Myocarditis | 1 | 2023 | 766 | 0.520 |
Why?
|
Carotid Stenosis | 1 | 2023 | 872 | 0.520 |
Why?
|
Tachycardia, Ventricular | 1 | 2024 | 1302 | 0.500 |
Why?
|
Anemia | 2 | 2024 | 1511 | 0.490 |
Why?
|
Pulmonary Veins | 1 | 2021 | 745 | 0.490 |
Why?
|
Antiviral Agents | 4 | 2023 | 3061 | 0.490 |
Why?
|
Vaccines | 1 | 2023 | 833 | 0.480 |
Why?
|
Administration, Oral | 6 | 2023 | 4045 | 0.480 |
Why?
|
Cardiomyopathies | 2 | 2024 | 1946 | 0.480 |
Why?
|
Chest Pain | 2 | 2023 | 1106 | 0.470 |
Why?
|
Contrast Media | 4 | 2023 | 5300 | 0.470 |
Why?
|
Coronary Occlusion | 2 | 2014 | 308 | 0.470 |
Why?
|
Femoral Artery | 6 | 2023 | 838 | 0.460 |
Why?
|
Dyslipidemias | 1 | 2021 | 895 | 0.460 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 865 | 0.450 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2023 | 1300 | 0.450 |
Why?
|
Patient Admission | 1 | 2021 | 1384 | 0.450 |
Why?
|
Dilatation, Pathologic | 1 | 2015 | 527 | 0.440 |
Why?
|
Behcet Syndrome | 1 | 2014 | 86 | 0.440 |
Why?
|
Predictive Value of Tests | 10 | 2024 | 15272 | 0.440 |
Why?
|
Cardiac Surgical Procedures | 3 | 2023 | 3618 | 0.430 |
Why?
|
Mortality | 4 | 2020 | 2916 | 0.430 |
Why?
|
Electrocardiography | 4 | 2022 | 6412 | 0.430 |
Why?
|
Respiration, Artificial | 2 | 2023 | 2623 | 0.420 |
Why?
|
Paclitaxel | 1 | 2020 | 1738 | 0.420 |
Why?
|
Hypercholesterolemia | 3 | 2024 | 1155 | 0.410 |
Why?
|
Aspirin | 3 | 2023 | 3365 | 0.400 |
Why?
|
Incidence | 16 | 2023 | 21379 | 0.390 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1007 | 0.380 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2161 | 0.380 |
Why?
|
Aortic Aneurysm | 3 | 2020 | 646 | 0.360 |
Why?
|
Prosthesis Design | 6 | 2024 | 2127 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12280 | 0.360 |
Why?
|
Interleukin-6 | 1 | 2020 | 3207 | 0.360 |
Why?
|
Radial Artery | 4 | 2020 | 197 | 0.350 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3145 | 0.350 |
Why?
|
Intracranial Embolism | 2 | 2021 | 192 | 0.340 |
Why?
|
Vascular Patency | 2 | 2023 | 904 | 0.330 |
Why?
|
Influenza, Human | 1 | 2020 | 1532 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2253 | 0.310 |
Why?
|
Brain Ischemia | 1 | 2022 | 3128 | 0.310 |
Why?
|
Thrombectomy | 3 | 2022 | 708 | 0.300 |
Why?
|
Atrial Appendage | 2 | 2022 | 292 | 0.300 |
Why?
|
Hospitals | 6 | 2023 | 3930 | 0.290 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1047 | 0.290 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 2469 | 0.290 |
Why?
|
Logistic Models | 5 | 2023 | 13315 | 0.280 |
Why?
|
Aortic Valve Insufficiency | 2 | 2022 | 584 | 0.280 |
Why?
|
Vaccination | 3 | 2023 | 3360 | 0.270 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2022 | 621 | 0.270 |
Why?
|
Length of Stay | 8 | 2023 | 6474 | 0.270 |
Why?
|
Dementia | 1 | 2021 | 2638 | 0.270 |
Why?
|
Blood Coagulation | 2 | 2023 | 1156 | 0.260 |
Why?
|
Lung | 2 | 2022 | 9988 | 0.260 |
Why?
|
Biphenyl Compounds | 2 | 2021 | 988 | 0.260 |
Why?
|
Tissue Plasminogen Activator | 2 | 2022 | 1190 | 0.260 |
Why?
|
Ventricular Function, Left | 6 | 2023 | 3871 | 0.250 |
Why?
|
Follow-Up Studies | 10 | 2022 | 39256 | 0.240 |
Why?
|
Palliative Care | 1 | 2020 | 3607 | 0.240 |
Why?
|
Sternotomy | 2 | 2022 | 127 | 0.240 |
Why?
|
Cardiomyopathy, Restrictive | 2 | 2022 | 62 | 0.240 |
Why?
|
Pandemics | 6 | 2022 | 8621 | 0.240 |
Why?
|
Prognosis | 11 | 2024 | 29640 | 0.230 |
Why?
|
United States | 16 | 2024 | 72369 | 0.230 |
Why?
|
Plaque, Atherosclerotic | 3 | 2024 | 1520 | 0.230 |
Why?
|
Comorbidity | 8 | 2024 | 10553 | 0.230 |
Why?
|
Prospective Studies | 11 | 2023 | 54265 | 0.220 |
Why?
|
Limb Salvage | 2 | 2023 | 468 | 0.220 |
Why?
|
Adult | 29 | 2024 | 219843 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20483 | 0.220 |
Why?
|
Echocardiography | 3 | 2023 | 4980 | 0.220 |
Why?
|
Pacemaker, Artificial | 3 | 2024 | 815 | 0.220 |
Why?
|
Severity of Illness Index | 11 | 2024 | 15828 | 0.220 |
Why?
|
Empyema, Pleural | 1 | 2023 | 61 | 0.210 |
Why?
|
Medicare | 4 | 2024 | 6771 | 0.210 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2024 | 865 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7469 | 0.210 |
Why?
|
Endarterectomy | 1 | 2023 | 196 | 0.210 |
Why?
|
Famotidine | 1 | 2021 | 17 | 0.200 |
Why?
|
Heart Septum | 1 | 2023 | 303 | 0.200 |
Why?
|
Bacillus | 1 | 2022 | 78 | 0.200 |
Why?
|
Weather | 2 | 2020 | 227 | 0.200 |
Why?
|
Bradycardia | 1 | 2023 | 298 | 0.190 |
Why?
|
Embolic Protection Devices | 1 | 2021 | 44 | 0.190 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2021 | 17 | 0.190 |
Why?
|
Natriuretic Peptides | 1 | 2022 | 156 | 0.190 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2021 | 94 | 0.190 |
Why?
|
Hypothermia | 1 | 2022 | 188 | 0.190 |
Why?
|
Administration, Inhalation | 2 | 2021 | 1156 | 0.190 |
Why?
|
Neoplasms | 4 | 2023 | 22066 | 0.190 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2022 | 122 | 0.190 |
Why?
|
Conjunctivitis, Viral | 1 | 2020 | 6 | 0.190 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1097 | 0.180 |
Why?
|
Marfan Syndrome | 1 | 2022 | 236 | 0.180 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15739 | 0.180 |
Why?
|
Perindopril | 1 | 2020 | 13 | 0.180 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2022 | 238 | 0.170 |
Why?
|
Odds Ratio | 3 | 2021 | 9714 | 0.170 |
Why?
|
Pleural Effusion | 1 | 2023 | 343 | 0.170 |
Why?
|
Wind | 1 | 2019 | 41 | 0.170 |
Why?
|
Hypothermia, Induced | 2 | 2022 | 758 | 0.170 |
Why?
|
Cause of Death | 5 | 2021 | 3723 | 0.170 |
Why?
|
Prosthesis Failure | 2 | 2023 | 1206 | 0.170 |
Why?
|
Propensity Score | 6 | 2022 | 1921 | 0.170 |
Why?
|
Hospitals, Community | 1 | 2022 | 367 | 0.170 |
Why?
|
Obesity | 1 | 2021 | 12913 | 0.170 |
Why?
|
Disease Progression | 4 | 2022 | 13503 | 0.170 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.170 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12159 | 0.160 |
Why?
|
Recreation | 1 | 2019 | 120 | 0.160 |
Why?
|
Postoperative Hemorrhage | 2 | 2019 | 422 | 0.160 |
Why?
|
Albuterol | 1 | 2020 | 212 | 0.160 |
Why?
|
Risk | 2 | 2022 | 9629 | 0.160 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 346 | 0.160 |
Why?
|
Immunization, Passive | 1 | 2021 | 616 | 0.160 |
Why?
|
Renin-Angiotensin System | 2 | 2021 | 739 | 0.160 |
Why?
|
Carotid Arteries | 1 | 2023 | 951 | 0.160 |
Why?
|
Eggs | 1 | 2020 | 183 | 0.160 |
Why?
|
Critical Illness | 2 | 2021 | 2710 | 0.160 |
Why?
|
Advance Directives | 1 | 2020 | 248 | 0.160 |
Why?
|
Vasodilator Agents | 1 | 2023 | 977 | 0.160 |
Why?
|
Recurrence | 3 | 2024 | 8487 | 0.160 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2020 | 218 | 0.150 |
Why?
|
Tissue and Organ Harvesting | 1 | 2021 | 377 | 0.150 |
Why?
|
Peptide Fragments | 2 | 2022 | 5120 | 0.150 |
Why?
|
Surgical Instruments | 1 | 2020 | 385 | 0.150 |
Why?
|
Policy | 1 | 2022 | 511 | 0.150 |
Why?
|
Marriage | 1 | 2019 | 351 | 0.150 |
Why?
|
Titanium | 1 | 2020 | 484 | 0.150 |
Why?
|
Gadolinium | 1 | 2023 | 958 | 0.150 |
Why?
|
Survival Rate | 6 | 2021 | 12806 | 0.150 |
Why?
|
Area Under Curve | 1 | 2022 | 1635 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2024 | 3524 | 0.150 |
Why?
|
Adolescent | 8 | 2024 | 87749 | 0.150 |
Why?
|
Mycoses | 1 | 2020 | 387 | 0.150 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1471 | 0.140 |
Why?
|
Drug Combinations | 2 | 2021 | 2024 | 0.140 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 392 | 0.140 |
Why?
|
Coronary Vasospasm | 1 | 2017 | 83 | 0.140 |
Why?
|
Popliteal Artery | 1 | 2019 | 315 | 0.140 |
Why?
|
Catheters | 2 | 2017 | 426 | 0.140 |
Why?
|
Mitral Valve Stenosis | 1 | 2019 | 348 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2019 | 274 | 0.140 |
Why?
|
Age Factors | 7 | 2024 | 18416 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2021 | 601 | 0.140 |
Why?
|
Heart Ventricles | 2 | 2020 | 3811 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 135 | 0.140 |
Why?
|
Extremities | 1 | 2022 | 867 | 0.140 |
Why?
|
Ethanol | 1 | 2023 | 1323 | 0.140 |
Why?
|
Television | 1 | 2019 | 409 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1207 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 516 | 0.140 |
Why?
|
Intracranial Hemorrhages | 1 | 2022 | 844 | 0.130 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2021 | 421 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2022 | 520 | 0.130 |
Why?
|
Spironolactone | 1 | 2020 | 411 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2021 | 1684 | 0.130 |
Why?
|
Aromatase Inhibitors | 1 | 2020 | 511 | 0.130 |
Why?
|
Tricuspid Valve | 1 | 2019 | 409 | 0.130 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2022 | 556 | 0.130 |
Why?
|
Geriatric Assessment | 1 | 2023 | 1405 | 0.130 |
Why?
|
Cold Temperature | 1 | 2019 | 780 | 0.130 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 593 | 0.130 |
Why?
|
Immunoconjugates | 1 | 2023 | 949 | 0.130 |
Why?
|
Coronary Stenosis | 1 | 2022 | 820 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 820 | 0.130 |
Why?
|
Prevalence | 9 | 2024 | 15684 | 0.130 |
Why?
|
Body Mass Index | 4 | 2022 | 12900 | 0.130 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4215 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 831 | 0.130 |
Why?
|
Comprehension | 1 | 2021 | 613 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1078 | 0.120 |
Why?
|
Bacteremia | 1 | 2022 | 979 | 0.120 |
Why?
|
Hemodynamics | 3 | 2020 | 4169 | 0.120 |
Why?
|
Amyloidosis | 1 | 2022 | 818 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1407 | 0.120 |
Why?
|
Child | 5 | 2023 | 79759 | 0.120 |
Why?
|
Lactic Acid | 1 | 2020 | 1132 | 0.120 |
Why?
|
Benzimidazoles | 1 | 2020 | 858 | 0.120 |
Why?
|
Sex Factors | 3 | 2024 | 10529 | 0.120 |
Why?
|
Gait | 1 | 2020 | 812 | 0.120 |
Why?
|
Patient Discharge | 3 | 2022 | 3476 | 0.110 |
Why?
|
Tetrazoles | 1 | 2020 | 901 | 0.110 |
Why?
|
Robotics | 1 | 2021 | 880 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 1016 | 0.110 |
Why?
|
Hot Temperature | 1 | 2020 | 1435 | 0.110 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12531 | 0.110 |
Why?
|
Heart Atria | 2 | 2023 | 1344 | 0.110 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 988 | 0.110 |
Why?
|
Fontan Procedure | 1 | 2019 | 791 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1031 | 0.110 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 20 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1973 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2063 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5725 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1387 | 0.100 |
Why?
|
Creatinine | 1 | 2018 | 1907 | 0.100 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 794 | 0.100 |
Why?
|
Azathioprine | 1 | 2014 | 356 | 0.100 |
Why?
|
Forecasting | 1 | 2022 | 2931 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2019 | 1500 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1402 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2022 | 2143 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4900 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1174 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4361 | 0.100 |
Why?
|
Coronary Thrombosis | 1 | 2015 | 486 | 0.100 |
Why?
|
Cohort Studies | 5 | 2024 | 41316 | 0.100 |
Why?
|
Social Class | 1 | 2020 | 2005 | 0.100 |
Why?
|
Endoscopy | 1 | 2021 | 1841 | 0.100 |
Why?
|
Hepatitis C | 1 | 2021 | 1578 | 0.090 |
Why?
|
Young Adult | 6 | 2024 | 58673 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10185 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3726 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2178 | 0.090 |
Why?
|
Osteoporosis | 1 | 2020 | 1600 | 0.090 |
Why?
|
Feeding Behavior | 2 | 2020 | 3185 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5201 | 0.090 |
Why?
|
Immunosuppressive Agents | 3 | 2022 | 4168 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 1275 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 344 | 0.080 |
Why?
|
Pulmonary Artery | 2 | 2022 | 1919 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4391 | 0.080 |
Why?
|
Prednisone | 1 | 2014 | 1566 | 0.080 |
Why?
|
Parents | 1 | 2023 | 3547 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2510 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1820 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4441 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1926 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2580 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2020 | 2317 | 0.080 |
Why?
|
Tissue Donors | 3 | 2022 | 2314 | 0.080 |
Why?
|
Reoperation | 3 | 2024 | 4293 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3822 | 0.080 |
Why?
|
Inflammation | 2 | 2020 | 10758 | 0.080 |
Why?
|
Graft Rejection | 4 | 2022 | 4423 | 0.080 |
Why?
|
Cities | 2 | 2020 | 538 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2023 | 12763 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3737 | 0.070 |
Why?
|
Models, Statistical | 1 | 2022 | 5072 | 0.070 |
Why?
|
Bone Density | 1 | 2020 | 3528 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5066 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7802 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 4668 | 0.070 |
Why?
|
Temperature | 2 | 2022 | 2221 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 6181 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3223 | 0.060 |
Why?
|
Sepsis | 1 | 2020 | 2594 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 7071 | 0.060 |
Why?
|
Child, Preschool | 3 | 2023 | 42036 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3380 | 0.060 |
Why?
|
Postoperative Period | 2 | 2020 | 1821 | 0.060 |
Why?
|
Angiography | 2 | 2024 | 1605 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4649 | 0.060 |
Why?
|
Ischemia | 2 | 2023 | 1897 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1411 | 0.050 |
Why?
|
Corn Oil | 1 | 2022 | 30 | 0.050 |
Why?
|
Mineral Oil | 1 | 2022 | 25 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4762 | 0.050 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 82 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5248 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2023 | 326 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 105 | 0.050 |
Why?
|
Deoxyribonucleases | 1 | 2023 | 212 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6167 | 0.050 |
Why?
|
Equipment Design | 2 | 2024 | 3521 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4687 | 0.050 |
Why?
|
Aorta, Abdominal | 1 | 2024 | 622 | 0.050 |
Why?
|
Graft Survival | 2 | 2022 | 3793 | 0.050 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2021 | 144 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 29727 | 0.050 |
Why?
|
Ramipril | 1 | 2021 | 97 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 388 | 0.050 |
Why?
|
Ultrasonography | 1 | 2014 | 5960 | 0.050 |
Why?
|
Regression Analysis | 2 | 2020 | 6361 | 0.050 |
Why?
|
Intermittent Claudication | 1 | 2023 | 307 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2022 | 272 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13629 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1100 | 0.040 |
Why?
|
Thoracotomy | 1 | 2021 | 362 | 0.040 |
Why?
|
Heart-Lung Transplantation | 1 | 2020 | 87 | 0.040 |
Why?
|
Antilymphocyte Serum | 1 | 2021 | 482 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7268 | 0.040 |
Why?
|
Enalapril | 1 | 2021 | 313 | 0.040 |
Why?
|
Septal Occluder Device | 1 | 2020 | 126 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2024 | 705 | 0.040 |
Why?
|
Debridement | 1 | 2021 | 492 | 0.040 |
Why?
|
Waiting Lists | 1 | 2023 | 754 | 0.040 |
Why?
|
Coma | 1 | 2022 | 487 | 0.040 |
Why?
|
Brain Death | 1 | 2022 | 356 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 265 | 0.040 |
Why?
|
Neprilysin | 1 | 2021 | 472 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 418 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1376 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2022 | 613 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1126 | 0.040 |
Why?
|
No-Reflow Phenomenon | 1 | 2017 | 17 | 0.040 |
Why?
|
Databases, Factual | 2 | 2024 | 8022 | 0.040 |
Why?
|
Cholesterol, HDL | 1 | 2023 | 1817 | 0.040 |
Why?
|
Cattle | 1 | 2023 | 3847 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 1004 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1272 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13249 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 582 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16543 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 920 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1810 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 912 | 0.030 |
Why?
|
Fever | 1 | 2022 | 1618 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2020 | 884 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1548 | 0.030 |
Why?
|
Hospital Costs | 1 | 2021 | 978 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1679 | 0.030 |
Why?
|
Protein Precursors | 1 | 2018 | 1135 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1786 | 0.030 |
Why?
|
Hepacivirus | 1 | 2021 | 1333 | 0.030 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 819 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2023 | 2422 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1130 | 0.030 |
Why?
|
Abdomen | 1 | 2020 | 1125 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2195 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7398 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21065 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1259 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4814 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2731 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2013 | 292 | 0.030 |
Why?
|
Income | 1 | 2020 | 1876 | 0.020 |
Why?
|
Liver Diseases | 1 | 2020 | 1301 | 0.020 |
Why?
|
Perioperative Care | 1 | 2019 | 1032 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2627 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4127 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13301 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36230 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12968 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1915 | 0.020 |
Why?
|
Recovery of Function | 1 | 2020 | 2983 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3389 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2020 | 2093 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10828 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2013 | 926 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36032 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2013 | 1578 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14481 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8058 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 1038 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12959 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20045 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9274 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22040 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11708 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167935 | 0.010 |
Why?
|